Skip to content
Research Article Open access CC BY 4.0

Pharmaco-Invasive Therapy is a Critical Option in Nigerian Stemi Treatment: A Review

Emmanuel Auchi Edafe, Johnbull Jumbo

Journal of Advances in Medical and Pharmaceutical Sciences · pp. 6–17 · Published 20 Oct 2023

10.9734/jamps/2023/v25i10645

Abstract

Primary percutaneous coronary intervention (PCI) is the recommended reperfusion approach in patients with ST-segment elevation myocardial infarction (STEMI), When conducted in a timely and by skilled operators. This technique, however, has proven to have limitations in areas without PCI facilities and with long wait times between the initial medical contact and balloon because to logistical issues and a lack of skilled operators.  In STEMI patients, pre-treatment with a fibrinolytic prior to PCI has the potential to give early pharmacologic reperfusion before definitive PCI. According to current evidence, assisted PCI has no advantage over main PCI.  The role for pharmaco-invasive reperfusion, defined as pharmacological re-perfusion followed by rapid transfer for routine delayed coronary angiography and PCI may still be considered in centers without on-site PCI capability. Patients presenting with STEMI in Nigeria have a lot of challenges which include delay in decision making, cost of revascularization, religious believes, ignorance and availability of cardiac catheterization and the skillful personnel for the operation. To meet with the demand and challenges of Myocardial infarction in Nigeria, we need the mode of treatment that is beneficial, cost effective and lifesaving. Hence, pharmaco-invasive is the way for Nigeria and other low-income countries of sub-Saharan Africa.

Pharmacoinvasive percutaneous coronary intervention myocardial infarction facilitated

References (11)

  1. 1 Ischaemic heart disease in Africa [DOI]
  2. 2 The Strategic Reperfusion Early After Myocardial Infarction (STREAM) study [DOI]
  3. 3 More Rapid, Complete, and Stable Coronary Thrombolysis With Bolus Administration of Reteplase Compared With Alteplase Infusion in Acute Myocardial Infarction [DOI]
  4. 4 Trends in coronary artery disease and associated risk factors in sub-Saharan Africans [DOI]
  5. 5 Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction [DOI]
  6. 6 Changing Trend in Coronary Heart Disease in Nigeria
  7. 7 Two-year follow-up data from the STEPP-AMI study: A prospective, observational, multicenter study comparing tenecteplase-facilitated PCI versus primary PCI in Indian patients with STEMI [DOI]
  8. 8 Overview of Reteplase, A Novel Thrombolytic Agent in Indian Context [DOI]
  9. 9 Expert consensus document on management of ST-Elevation myocardial infarction: Adaptation of 2012 ESC guidelines [DOI]
  10. 10 Vascular Health and Risk Management [DOI]
  11. 11 A history of streptokinase use in acute myocardial infarction.

Cited by 1

The STEMI Pharmaco-Invasive Therapy in Africa: Bridging the Gap

Emmanuel Auchi Edafe, Maclean Akpa, Muhammad Nazir Shehu · Cardiology and cardiovascular research. · 2023

Related research

Article metrics

Real usage data collected on this platform.

8

Page views

0

PDF downloads

0

Outbound clicks

1

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.